Skip to content

An exploratory study on the effects of continuous intake of almond meal on health conditions

An exploratory study on the effects of continuous intake of almond meal on health conditions - An exploratory study on the effects of continuous intake of almond meal on health conditions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048577
Enrollment
20
Registered
2022-08-04
Start date
2022-08-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Consume 20 g of almond meal daily for 2 weeks

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2. Healthy Japanese who are 20 years old or more and under 65 years old

Exclusion criteria

Exclusion criteria: 1. Persons who have chronic illness, receiving medication, have a serious disease history 2. Persons who are allergic to the test food or almond 3. Persons who regularly take a large amount of test food or almonds 4. Persons who regularly take medicines or foods with health claims that may affect the intestinal environment, immunity, and antioxidant effects, or nutritional supplements to supplement proteins. 5. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 6. Persons who were judged as inappropriate for study participants by the principal investigator 7. Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Design outcomes

Primary

MeasureTime frame
Intestinal environment (urinary indoxyl sulfate, urinary creatinine) before and after ingestion

Secondary

MeasureTime frame
Oxidative stress level(urinary 8-OHdG, urinary creatinine) Protein adequacy test (urinary urea nitrogen, urinary creatinine) Immune test (IgA in saliva) before and after ingestion

Countries

Japan

Contacts

Public ContactYoshikatsu Hosoya

Healthcare Systems Co., Ltd. Sales Planning Department

hosoya@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026